Yeah except they never said the battery business would be funded from free cashflow.
That's correct. But free funds and positive results could have been an important component for future funding and, above all, would have created TRUST.
This trust has currently at least been lost somewhat - although Corona was of course not foreseeable in advance when all studies were carried out and one cannot blame the management for this.
I still think that the news published today should have been published beforehand. That would have created trust, especially since nothing was heard from JB regarding the current problems at any point in the last interviews, although these had been known since late June - I have to blame JB for that!
The future could still be excellent (battery-compatible manganese, acceptance agreement), but it has got slight scratches at the moment - and rightly so!
Scoping study at the end of the year is unlikely to be the increased breakthrough because there is currently a lack of trust.
The day before yesterday I bought more and if the share price continues to fall, I will buy again and increase the price, because my entry here was already at 0.10 AUD - when Rocket was still for sale - and I continue to believe in the future of this company!
Many Grettings from Germany!
- Forums
- ASX - By Stock
- E25
- Ann: Revised Shipping Strategy Yields Substantial Cost Reduction
E25
element 25 limited
Add to My Watchlist
0.00%
!
22.5¢

Ann: Revised Shipping Strategy Yields Substantial Cost Reduction, page-73
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $21.94K | 100.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 62609 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 0.215 |
2 | 5119 | 0.210 |
2 | 8107 | 0.205 |
7 | 59405 | 0.200 |
3 | 13077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 62609 | 2 |
0.230 | 72958 | 1 |
0.235 | 24800 | 2 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online